Gene · 10155
Papers3,480
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
101 to 120 of 3,480
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| A non-canonical EZH2/TRIM28 epigenetic axis drives heparan sulfate remodeling and melanoma metastasis. | bioRxiv | 2026 | 41648528 | PubTator, text mining | PubMed |
| Author Correction: TRIM28-mediated nucleocapsid protein SUMOylation enhances SARS-CoV-2 virulence. | Nat Commun | 2026 | 41644946 | PubTator, text mining | PubMed |
| Loss of SETDB1-mediated H3K9me3 in human neural progenitor cells leads to transcriptional activation of L1 retrotransposons. | Nucleic Acids Res | 2026 | 41641702 | PubTator, text mining | PubMed |
| SUMOylation is destined for regulatory T cell-related immune dysregulation. | Cell Death Discov | 2026 | 41633969 | PubTator, text mining | PubMed |
| Germline duplication of MYCN predisposes to childhood embryonal tumours. | EBioMedicine | 2026 | 41621405 | PubTator, text mining | PubMed |
| Comprehensive profiling of CRISPR/dCas9 epigenome editors indicates a complex link between on and off target effects. | Genome Biol | 2026 | 41620608 | PubTator, text mining | PubMed |
| The dual promise of extracellular vesicles in lung diseases: towards reliable biomarkers and drug delivery vectors. | Eur Respir Rev | 2026 | 41605536 | PubTator, text mining | PubMed |
| Roles of TIF1β in Leukemic Stem Cell Through SETDB1-Dependent and Independent Mechanisms. | Cancer Sci | 2026 | 41601208 | PubTator, text mining | PubMed |
| Histone H3.3 phosphorylation facilitates H3K9me3-heterochromatin formation during retrotransposon silencing and X-chromosome inactivation via H3.3K27me3-CBX7-KAP1 axis. | Sci Bull (Beijing) | 2026 | 41582043 | PubTator, text mining | PubMed |
| Autophagic molecular network in IS pathogenesis: A multi-omics Mendelian randomization study. | Medicine (Baltimore) | 2026 | 41578456 | PubTator, text mining | PubMed |
| Reprogramming the epigenetic profile improves the B regulatory cell function of patients with recurrent pregnancy loss. | Cell Commun Signal | 2026 | 41578369 | PubTator, text mining | PubMed |
| Screening of kinase-related genes as diagnostic biomarkers and immune infiltration analysis in sepsis. | Immunobiology | 2026 | 41570454 | PubTator, text mining | PubMed |
| COVID-19 immunopathological features for the prediction and prevention of future emerging respiratory viral infections. | Comput Struct Biotechnol J | 2026 | 41551039 | PubTator, text mining | PubMed |
| Ginsenoside Rg3 antagonises endometriosis glycolysis via the tripartite motif containing 28 and pyruvate dehydrogenase kinase 4 signalling pathway. | Phytomedicine | 2026 | 41539092 | PubTator, text mining | PubMed |
| Tissue-specific restriction of transposon-derived regulatory elements safeguards cell-type identity. | Cell Rep | 2026 | 41538330 | PubTator, text mining | PubMed |
| Targeting the TRIM28-EZH2 Protein-Protein Interface With Cysteine-Reactive Covalent Inhibitors: A Computational Blueprint for Cancer Therapy. | Chem Biodivers | 2026 | 41504013 | PubTator, text mining | PubMed |
| PDZRN4 suppresses lung adenocarcinoma progression via inhibiting ubiquitin-mediated HIF-1A degradation. | Oncogene | 2026 | 41461926 | PubTator, text mining | PubMed |
| The combined treatment with TOP-V122, a dual-acting NO-releasing PDE-5 inhibitor, and ionizing irradiation as a novel therapeutical strategy for colorectal carcinoma. | Radiother Oncol | 2026 | 41389859 | PubTator, text mining | PubMed |
| Crosstalk between myostatin and callipyge in CRISPR/Cas9-edited goat fibroblast cells. | Res Vet Sci | 2026 | 41330077 | PubTator, text mining | PubMed |
| CRISPR/Cas9 library screening uncovered CCT2 as a critical driver of acquired resistance to EGFR-targeted therapy by stabilizing TMX1 in non-small cell lung cancer. | Cell Death Differ | 2026 | 41168408 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/10155/papers?page=6